Abstract P001: Plasma Phospholipid Saturated Fatty Acids and Incident Atrial Fibrillation: the Cardiovascular Health Study
Background: Prior studies suggest that circulating fatty acids may influence the risk of atrial fibrillation (AF), but little is known about the associations of circulating saturated fatty acids (SFA) with risk of AF. SFAs of different length differ in dietary and metabolic origin, incorporation into membrane lipid species, membrane properties, and biological activities that may influence the pathophysiology of AF. Moreover, both diet and metabolic pathways are determinants of circulating SFAs.
Methods: The study population included 2,899 participants from the Cardiovascular Health Study, a community-based longitudinal cohort of adults aged 65 years or older, free of prevalent coronary heart disease and AF. Cox regression was used to assess the association of all the long-chain saturated fatty acids, palmitic acid (16:0), stearic acid (18:0), arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0), with incident AF.
Results: During 29,864 person-years of follow-up, 707 cases of incident AF occurred. After adjustment for other AF risk factors, higher levels of circulating 16:0 were associated with a higher risk of AF (hazard ratio comparing highest to lowest quartiles: 1.48. 95% CI: 1.18, 1.86). On the other hand, higher levels of circulating 18:0, 20:0, 22:0 and 24:0 were each associated with a lower risk of AF. The hazard ratios (95% CI) for AF in the top versus bottom quartile were 0.76 (0.61, 0.95) for 18:0; 0.78 (0.63, 0.97) for 20:0; 0.62 (0.50, 0.78) for 22:0; and 0.68 (0.55, 0.85) for 24:0.
Conclusions: Results from this prospective cohort study of older adults demonstrate divergent associations of circulating 16:0 versus longer-chain saturated fatty acids with incident AF, highlighting the need to investigate both determinants of these levels and potential pathways of the observed differential risk.
Author Disclosures: D. Mozaffarian: E. Honoraria; Modest; International Life Sciences Institute, Bunge. G. Consultant/Advisory Board; Modest; Foodminds, McKinsey Health Systems Institute, Nutrition Impact, Unilever North America. D.S. Siscovick: None. L. Djousse: C. Other Research Support; Modest; California Walnut Commission. H. Other; Modest; Hershey, International Nut and Dried Fruit. S.R. Heckbert: None. I.B. King: None. B. McKnight: None. C. Sitlani: None. F.M. Sacks: None. X. Song: None. N. Sotoodehnia: None. D. Spiegelman: None. E.R. Wallace: None. R.N. Lemaitre: None.
- © 2014 by American Heart Association, Inc.